Skip to navigationSkip to contentSkip to footerHelp using this website - Accessibility statement
  • Advertisement
    Companies

    Healthcare & Fitness

    Today

    Majority owner Crescent Capital Partners has been on the register since 2012.

    Crescent launches $43m block trade in ClearView Wealth

    Stockbroker Morgans Financial was seeking buyers at 59¢ a share or a 1.7 per cent discount to the last traded price.

    • Sarah Thompson, Kanika Sood and Emma Rapaport

    Yesterday

    Regis founders Ian Roberts and Bryan Dorman.

    Fundies have Regis Healthcare founder’s stake on their watch lists

    The market has a close eye on founding director Bryan Dorman’s stake in the $1.2 billion aged care provider.

    • Sarah Thompson, Kanika Sood and Emma Rapaport

    This Month

    Healthscope has a contract with the NSW government to run the public wing of Northern Beaches Hospital until 2038.

    Brookfield’s Healthscope debt trap is a mess for everyone involved

    The investment giant is bringing its punchy approach to restructuring – and tactics more often found in the US – to Australia as it works on the hospital group.

    • Jemima Whyte
    21 per cent of US concussions are sporting injuries, according to Nurochek.

    Concussion medtech start-up kicks off raise for US expansion

    Headsafe hoping to break into the United States healthcare market with its NuroCHEK device, hitting up early-stage investors for $5 million.

    • Sarah Thompson, Kanika Sood and Emma Rapaport
    G8 Education is Australia’s biggest for-profit childcare operator.

    G8 Education board faces investor scepticism over Star links

    The biggest for-profit operator of childcare also revealed some problems had struck a controversial deal to offload underperforming centres.

    • Liam Walsh
    Advertisement
    UK private equity firm Livingbridge invested in Habit Health in 2018.

    New deal! Five V Capital are creatures of Habit

    Allied health providers have proved popular – and profitable – for a number of investors, including Quadrant Private Equity, Next Capital and Adamantem Capital.

    • Sarah Thompson, Kanika Sood and Emma Rapaport
    Hot flushes are one of many bothersome symptoms of menopause.

    Menopause hormone therapy is OK after all, long-term study finds

    Since a study in 2002 was called off, women have been reluctant to take hormones. But a new study has reassuring news for women under 60.

    • Marlene Cimons
    Peloton is suffering a market and share slump.

    Peloton crashes to record low as CEO quits amid lay-offs

    The interactive exercise bike company was a pandemic superstar but is now struggling heavily and laying off 15 per cent of the workforce.

    • Mark Gurman

    April

    Chemist Warehouse’s deal to list via Sigma Healthcare is part way through an ACCC merger review.

    How Chemist Warehouse can get its deal past the ACCC

    Divestments may be needed to get the Chemist Warehouse/Sigma deal over the line, but they don’t look too strenuous.

    • Updated
    • Anthony Macdonald
    Healthscope CEO Greg Horan says the sector is under serious pressure as costs rise.

    Healthscope in $919m writedown as hospital costs jump

    One of Australia’s biggest private hospital operators plunged into the red as wage and medical supplies costs climbed, and it booked a big impairment.

    • Simon Evans
    Benson Radiology’s Christies Beach location (pictured) is one of its 24 clinics across South Australia.

    SA’s Benson Radiology orders adviser beauty parade

    Sources said Benson is making about $30 million EBITDA a year.

    • Sarah Thompson, Kanika Sood and Emma Rapaport
    Doubel act: I-MED CEO Shrey Viranna and his chairman, George Savvides, oversee one of the biggest privatley owned health businesses in Australia.

    How under the radar I-MED is fighting fit after 20-year PE job

    Tucked away in private equity, it is easy to forget about Australia’s biggest imaging company I-MED. But it is worth watching this year; it has a few ideas on the boil.

    • Anthony Macdonald
    Former Telstra CEO David Thodey read the room when he took over as Ramsay Health Care’s chairman.

    Adieu: Ramsay Health Care’s shrinking global ambition

    Under-pressure Ramsay Health Care is taking a fresh look at its footprint, which could mean a major change in its strategy. Watch this space.

    • Anthony Macdonald
    APM chief Michael Anghie and founder Megan Wynne when the company listed in 2021.

    Private equity back to clean up its mess at troubled jobs agency

    Jobs agency APM’s situation gets more bizarre as it goes looking for another frog to kiss.

    • Anthony Macdonald
    Former premier Mike Baird, pictured with former NAB chief Andrew Thorburn, upon joining the bank in April 2017.

    Andrew Thorburn lands CEO role at HammondCare

    At his new job, the one-time NAB CEO’s Christianity is unlikely to be an issue.

    • Myriam Robin
    Advertisement

    Ansell shows how to create new interest in an old story

    Cheap stock never goes out of fashion. The key for a company is to issue it only occasionally, and make the most of when it does.

    • Anthony Macdonald
    Atmo Biosciences says its technology offers better gut health.

    Medtech Atmo Biosciences shop raise at $55m valuation

    Alium Capital Management, Japanese pharmaceuticals giant Otsuka Pharmaceutical and Breakthrough Victoria are set to cornerstone Atmo Biosciences $15 million equity raise.

    • Sarah Thompson, Kanika Sood and Emma Rapaport

    March

    Cochlear chief executive Dig Howitt has had a great story to tell investors at recent results.

    Can a vaccine slow down the Cochlear train?

    Cochlear is firing for investors, but you have to wonder whether everyone’s getting a bit carried away.

    • Anthony Macdonald
    The pathology business is the largest division of Healius, which runs 2000 collection centres and 100 testing labs.

    Healius in management shake-up after CEO exit

    Australia’s No.2 pathology group is cutting costs in a restructure to try to turn around a profit slump, as UBS pushes on with a strategic review.

    • Simon Evans
    Megan Wynne, executive chair and founder of APM became a billionaire ahead of the IPO in late 2021, but the share price has tumbled. CVC has walked away from a $2 per share bid.

    Private equity group CVC walks away from $1.83b APM bid

    Rich Lister Megan Wynne built APM from scratch in 1994 into a large player generating fees from helping people find jobs, and has expanded as an NDIS provider.

    • Simon Evans